Institutional Investors May Overlook Bristol-Myers Squibb Company's (NYSE:BMY) Recent US$5.9b Market Cap Drop as Long-term Gains Remain Positive

Simply Wall St02:22

9 Health Care Stocks With Whale Alerts In Today's Session

Benzinga01:35

Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing

BenzingaDec 16 22:42

Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

BenzingaDec 16 21:37

Bristol-Myers Squibb Analyst Ratings

BenzingaDec 16 21:07 · Ratings

Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70

Futu NewsDec 16 20:34 · Ratings